A New Window into Portal Flow: MRI Biomarkers for High-Risk Varices
A recent exploratory study in the Journal of Magnetic Resonance Imaging demonstrates the potential of 4D flow MRI to assess portal venous hemodynamics as a noninvasive biomarker for high-risk esophageal varices in patients with liver cirrhosis. The research, involving 104 cirrhotic patients, found that while traditional metrics like flow rate and velocity showed some differentiation, a key rotational flow biomarker—vorticity—significantly distinguished patients with high-risk varices from those with low-risk or no varices. This advanced cardiac imaging technique achieved an area under the ROC curve of 0.77, suggesting vorticity could serve as a complementary tool for cardiovascular risk prediction in this complex patient population, potentially reducing reliance on more invasive endoscopic procedures.
Study Significance: For cardiologists and vascular specialists, this study highlights the expanding utility of advanced flow imaging beyond traditional cardiac chambers to the portal venous system, offering a novel hemodynamic biomarker. It underscores a translational shift where sophisticated cardiac MRI techniques developed for assessing conditions like valvular heart disease or aortic stenosis are being repurposed to solve critical problems in hepatology, specifically the stratification of bleeding risk. This cross-disciplinary application reinforces the central role of vascular biology and hemodynamic assessment in managing systemic complications of chronic diseases, potentially informing more personalized surveillance strategies.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
